6505--Tamoxifen Tablets (VA-22-00003020)

Closed Pre-Solicitation Posted

This opportunity was awarded. See the award notice from , or the latest solicitation from .

Solicitation number
36E79721R0043
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

Notice text

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79721R0043 for an unrestrictive procurement for Tamoxifen Citrate Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number or UPC code. Solicitation 36E79721R0043 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about August 18, 2021, with a tentative closing date of September 1, 2021. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.beta.SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Adrienne A. Albachiara. Questions can be e-mailed to: adrienne.albachiara@va.gov.

The estimated annual requirements are as follows:

ITEM

DESCRIPTION

PACKAGE SIZE (BOTTLES)

TOTAL ESTIMATED ANNUAL USAGE (BOTTLES)

1

Tamoxifen Citrate 10mg Tablets

60

17,193

2

Tamoxifen Citrate 20mg Tablets

30

60,483

Items 1 and 2 Require Unit of Use Bottles. All unit of use packaging identified in the Schedule of Supplies, (i.e., 30s, 60s, 90s), all bottles shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.

Files

File Type Posted
36E79721R0043_1.docx DOCX document

Notice history

Notice Type Posted
6505--Tamoxifen Tablets (VA-22-00003020) Award Award Notice
6505--Tamoxifen Tablets (VA-22-00003020) Latest solicitation Solicitation
This notice Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors